Global Rare Disease Drug Market Study 2016-2026, by Segment (>1, 0.65 1, … …), by Market (Hospital Pharmacies, Speciality Pharmacies, … …), by Company (Novartis AG, Bristol-Myers Squibb Company, … …)
SKU ID :99ST-14631697 | Published Date: 29-Oct-2019 | No. of pages: 62Description
TOC
Table of Content
1 Industry Overview
1.1 Rare Disease Drug Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview
2 Rare Disease Drug Market by Type
2.1 By Type
2.1.1 >1
2.1.2 0.65 1
2.1.3 <0.1
2.2 Market Size by Type
2.3 Market Forecast by Type
3 Global Market Demand
3.1 Segment Overview
3.1.1 Hospital Pharmacies
3.1.2 Speciality Pharmacies
3.1.3 Retail pharmacies
3.1.4 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand
4 Major Region Market
4.1 Global Market Overview
4.1.1 Market Size & Growth
4.1.2 Market Forecast
4.2 Major Region
4.2.1 Market Size & Growth
4.2.2 Market Forecast
5 Major Companies List
5.1 Novartis AG (Company Profile, Sales Data etc.)
5.2 Bristol-Myers Squibb Company (Company Profile, Sales Data etc.)
5.3 Celgene Corporation (Company Profile, Sales Data etc.)
5.4 F. Hoffmann-La Roche Ltd. (Company Profile, Sales Data etc.)
5.5 Pfizer, Inc. (Company Profile, Sales Data etc.)
5.6 Sanofi S.A. (Company Profile, Sales Data etc.)
5.7 Alexion Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
5.8 Eli Lilly and Company (Company Profile, Sales Data etc.)
5.9 Novo Nordisk A/S (Company Profile, Sales Data etc.)
5.10 AstraZeneca (Company Profile, Sales Data etc.)
5.11 Eisai Co., Ltd. (Company Profile, Sales Data etc.)
5.12 Daiichi Sankyo Company Limited (Company Profile, Sales Data etc.)
5.13 Bayer AG (Company Profile, Sales Data etc.)
5.14 GlaxoSmithKline (Company Profile, Sales Data etc.)
5.15 Merck & Co., Inc. (Company Profile, Sales Data etc.)
5.16 Johnson & Johnson (Company Profile, Sales Data etc.)
5.17 Biogen, Inc. (Company Profile, Sales Data etc.)
5.18 Shire (Company Profile, Sales Data etc.)
5.19 Amgen, Inc. (Company Profile, Sales Data etc.)
5.20 Deciphera (Company Profile, Sales Data etc.)
5.21 Atara Biotherapeutics (Company Profile, Sales Data etc.)
5.22 ProQR (Company Profile, Sales Data etc.)
6 Conclusion
Tables & Figures
List of Table
Table Global Rare Disease Drug Market 2016-2019, by Type, in USD Million
Table Global Rare Disease Drug Market 2016-2019, by Type, in Volume
Table Global Rare Disease Drug Market Forecast 2020-2026, by Type, in USD Million
Table Global Rare Disease Drug Market Forecast 2020-2026, by Type, in Volume
Table Global Rare Disease Drug Demand 2016-2019, in USD Million
Table Global Rare Disease Drug Demand 2016-2019, in Volume
Table Global Rare Disease Drug Demand Forecast 2020-2026, in USD Million
Table Global Rare Disease Drug Demand Forecast 2020-2026, in Volume
Table Global Rare Disease Drug Market Size & Growth 2016-2019, in USD Million
Table Global Rare Disease Drug Market Size & Growth 2016-2019, in Volume
Table Global Rare Disease Drug Market Forecast 2020-2026, in USD Million
Table Global Rare Disease Drug Market Forecast 2020-2026, in Volume
Table Global Rare Disease Drug Market 2016-2019, by Region, in USD Million
Table Global Rare Disease Drug Market 2016-2019, by Region, in Volume
Table Global Rare Disease Drug Market Forecast 2020-2026, by Region, in USD Million
Table Global Rare Disease Drug Market Forecast 2020-2026, by Region, in Volume
Table Novartis AG Overview List
Table Rare Disease Drug Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis AG Overview List
Table Rare Disease Drug Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Company Overview List
Table Rare Disease Drug Business Operation of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celgene Corporation Overview List
Table Rare Disease Drug Business Operation of Celgene Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table F. Hoffmann-La Roche Ltd. Overview List
Table Rare Disease Drug Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer, Inc. Overview List
Table Rare Disease Drug Business Operation of Pfizer, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi S.A. Overview List
Table Rare Disease Drug Business Operation of Sanofi S.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Alexion Pharmaceuticals, Inc. Overview List
Table Rare Disease Drug Business Operation of Alexion Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly and Company Overview List
Table Rare Disease Drug Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novo Nordisk A/S Overview List
Table Rare Disease Drug Business Operation of Novo Nordisk A/S (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Rare Disease Drug Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eisai Co., Ltd. Overview List
Table Rare Disease Drug Business Operation of Eisai Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo Company Limited Overview List
Table Rare Disease Drug Business Operation of Daiichi Sankyo Company Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer AG Overview List
Table Rare Disease Drug Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Rare Disease Drug Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co., Inc. Overview List
Table Rare Disease Drug Business Operation of Merck & Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Rare Disease Drug Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biogen, Inc. Overview List
Table Rare Disease Drug Business Operation of Biogen, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Shire Overview List
Table Rare Disease Drug Business Operation of Shire (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen, Inc. Overview List
Table Rare Disease Drug Business Operation of Amgen, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Deciphera Overview List
Table Rare Disease Drug Business Operation of Deciphera (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Atara Biotherapeutics Overview List
Table Rare Disease Drug Business Operation of Atara Biotherapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ProQR Overview List
Table Rare Disease Drug Business Operation of ProQR (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
List of Figure
Figure Global Rare Disease Drug Market Growth 2016-2019, by Type, in USD Million
Figure Global Rare Disease Drug Market Growth 2016-2019, by Type, in Volume
Companies
- PRICE
-
$1800$3600